Trending

Autonomic Technologies asserted that the College of the French National Authority for Health issued a optimistic opinion on Forfait Innovation package for the Pulsante SPG…
Read More...

As far as an article published in Experimental Biology and Medicine is concerned, Experimental Biology and Medicine ascertains a new pathway that contributes to lung failure in patients…
Read More...

Malachite Management asserted that it has recently been granted accreditation by Association Management Company Institute (AMCI), the global trade association representing the…
Read More...

MiNA Therapeutics announced the publication of pre-clinical data on its MTL-CEBPA program in which the compound was shown to promote disease reversal in several models of liver disease…
Read More...

In a bid to expand its premium Cardiovascular ultrasound system that delivers a complete solution for structural heart analysis, Canon Medical Systems USA has introduced a new version…
Read More...

MiMedx Group which is a leading developer and marketer of regenerative and therapeutic biologics asserted that the U.S Food and Drug Administration has extended MiMedx's micronized…
Read More...

CTI BioPharma Corp asserted that results from the Phase 3 PERSIST-2 clinical Trial of pacritinib which is an investigational JAK22 inhibitor that has been published online in JAMA…
Read More...

FDA approved the conduct of a pivotal Clinical Trial incorporating new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologies, is…
Read More...

Amgen revealed that data from two new studies suggest barriers to access for PCSK9 inhibitors and the potential consequences of barring access for PCSK9 inhibitors and the potential…
Read More...

Abbott claimed new late-breaking Clinical Trial data from the MOMENTUM 3 clinical study which is the largest left ventricular assist device (LVAD) trial in the world to evaluate…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

InVivo Therapeutics Holdings Corporation became recipient of supplemental Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for a second…
Read More...

Ortho Clinical Diagnostics which is  a global leader of in vitro diagnostics asserted the launch of Ortho's VITROS Immunodiagnostic Products C-peptide Reagent Pack and Calibrators that…
Read More...

Wuxi Biologics and Adagene which is an emerging biotech company discovering and developing innovative antibody therapeutics for its usage globally, declared a collaboration agreement.…
Read More...

Prokaryotics receives $2.5 million from the National Institute of Allergy and Infectious Diseases as a SBIR. The two-year agreement will fund research by Prokaryotics on the restoration…
Read More...

Spinal Singularity declared that the first patient has been treated with the Connected Catheter which is an innovative, smart catheter system designed for adult males with Chronic…
Read More...

Sweetch which is a mobile-health app that helps prevent and enhance outcomes in diabetes by encouraging long-term behavioral change declared thee outcomes of its clinical trial…
Read More...

The American Diabetes Association issues new guidance, "Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A…
Read More...

Wuxi NextCODE which is an emerging global standard platform for genomic data asserted a partnership with Google Cloud that focuses to deliver comprehensive genomics capabilities to…
Read More...

Global life sciences company and a global leader in mammalian cell line generation technology, Selexis SA asserted that Compugen has obtained license to the Selexis SUREtechnology …
Read More...